SRRM4 and prostate carcinoma: Important SRRM4-regulated events include a splicing switch in the transcription factor REST1 (RE1 silencing transcription factor) which is a master regulator of neurogenesis, thus providing a possible molecular explanation for the neuroendocrine prostate cancer phenotype (Li et al. 2016).